Synapto-protective effect of lithium on HIV-1 Tat-induced synapse loss in rat hippocampal cultures

References

• Angelino AF, Treisman GJ. 2001. Management of psychiatric disorders in patients infected with human immunodeficiency virus. Clin Infect Dis. 33(6):847–856.
   PubMed Web of Science ®Google Scholar
• Arseniou S, Arvaniti A, Samakouri M. 2014. HIV infection and depression. Psychiatry Clin Neurosci. 68(2):96–109.
   PubMed Web of Science ®Google Scholar
• Bachani M, Sacktor N, McArthur JC, Nath A, Rumbaugh J. 2013. Detection of anti-tat antibodies in CSF of individuals with HIV-associated neurocognitive disorders. J Neurovirol. 19(1):82–88.
   PubMed Web of Science ®Google Scholar
• Berridge MJ. 1989. The Albert Lasker medical awards. Inositol trisphosphate, calcium, lithium, and cell signaling. JAMA. 262(13):1834–1841.
   PubMed Web of Science ®Google Scholar
• Beurel E, Jope RS. 2014. Inflammation and lithium: clues to mechanisms contributing to suicide-linked traits. Transl Psychiatry. 4:e488–e488.
   PubMed Web of Science ®Google Scholar
• Bonavia R, Bajetto A, Barbero S, Albini A, Noonan DM, Schettini G. 2001. HIV-1 Tat causes apoptotic death and calcium homeostasis alterations in rat neurons. Biochem Biophys Res Commun. 288(2):301–308.
   PubMed Web of Science ®Google Scholar
• Chiu CT, Wang Z, Hunsberger JG, Chuang DM. 2013. Therapeutic potential of mood stabilizers lithium and valproic acid: beyond bipolar disorder. Pharmacol Rev. 65(1):105–142.
   PubMed Web of Science ®Google Scholar
• Choi Y, Seo H, Cho M, Kim J, Chung HS, Lee I, Kim MJ. 2021. Rutin inhibits DRP1-mediated mitochondrial fission and prevents ethanol-induced hepatotoxicity in HepG2 cells and zebrafish. Anim Cells Syst. 25(1):74–81.
   PubMed Web of Science ®Google Scholar
• Colledge M, Snyder EM, Crozier RA, Soderling JA, Jin Y, Langeberg LK, Lu H, Bear MF, Scott JD. 2003. Ubiquitination regulates PSD-95 degradation and AMPA receptor surface expression. Neuron. 40(3):595–607.
   PubMed Web of Science ®Google Scholar
• Dell'Osso L, Del Grande C, Gesi C, Carmassi C, Musetti L. 2016. A new look at an old drug: neuroprotective effects and therapeutic potentials of lithium salts. Neuropsychiatr Dis Treat. 12:1687–1703.
   PubMed Web of Science ®Google Scholar
• Dou H, Ellison B, Bradley J, Kasiyanov A, Poluektova LY, Xiong H, Maggirwar S, Dewhurst S, Gelbard HA, Gendelman HE. 2005. Neuroprotective mechanisms of lithium in murine human immunodeficiency virus-1 encephalitis. J Neurosci. 25(37):8375–8385.
   PubMed Web of Science ®Google Scholar
• Dwivedi T, Zhang H. 2014. Lithium-induced neuroprotection is associated with epigenetic modification of specific BDNF gene promoter and altered expression of apoptotic-regulatory proteins. Front Neurosci. 8:457.
   PubMed Web of Science ®Google Scholar
• Eugenin EA, King JE, Nath A, Calderon TM, Zukin RS, Bennett MV, Berman JW. 2007. HIV-tat induces formation of an LRP-PSD-95- NMDAR-nNOS complex that promotes apoptosis in neurons and astrocytes. Proc Natl Acad Sci U S A. 104(9):3438–3443.
   PubMed Web of Science ®Google Scholar
• Everall IP, Bell C, Mallory M, Langford D, Adame A, Rockestein E, Masliah E. 2002. Lithium ameliorates HIV-gp120-mediated neurotoxicity. Mol Cell Neurosci. 21(3):493–501.
   PubMed Web of Science ®Google Scholar
• FI BRaT. 2006. In: Brunton LL, Parker KL, editor. Goodman and Gilman’s the pharmacological basis of therapeutics. 11th ed. New York: McGraw-Hill.
   Google Scholar
• Fitting S, Xu R, Bull C, Buch SK, El-Hage N, Nath A, Knapp PE, Hauser KF. 2010. Interactive comorbidity between opioid drug abuse and HIV-1 Tat: chronic exposure augments spine loss and sublethal dendritic pathology in striatal neurons. Am J Pathol. 177(3):1397–1410.
   PubMed Web of Science ®Google Scholar
• Gallicchio VS, Cibull ML, Hughes NK, Tse KF. 1993. Effect of lithium in murine immunodeficiency virus infected animals. Pathobiology. 61(3–4):216–221.
   PubMed Web of Science ®Google Scholar
• Genis P, Jett M, Bernton EW, Boyle T, Gelbard HA, Dzenko K, Keane RW, Resnick L, Mizrachi Y, Volsky DJ, et al. 1992. Cytokines and arachidonic metabolites produced during human immunodeficiency virus (HIV)-infected macrophage-astroglia interactions: implications for the neuropathogenesis of HIV disease. J Exp Med. 176(6):1703–1718.
   PubMed Web of Science ®Google Scholar
• Harvey BH, Meyer CL, Gallichio VS, Manji HK. 2002. Lithium salts in AIDS and AIDS-related dementia. Psychopharmacol Bull. 36(1):5–26.
   PubMedGoogle Scholar
• Hashimoto H, Kapiga SH, Murata Y. 2002. Mass treatment with nevirapine to prevent mother-to-child transmission of HIV/AIDS in sub-Saharan African countries. J Obstet Gynaecol Res. 28(6):313–319.
   PubMed Web of Science ®Google Scholar
• Haughey NJ, Nath A, Mattson MP, Slevin JT, Geiger JD. 2001. HIV-1 Tat through phosphorylation of NMDA receptors potentiates glutamate excitotoxicity. J Neurochem. 78(3):457–467.
   PubMed Web of Science ®Google Scholar
• Hibar DP, Stein JL, Renteria ME, Arias-Vasquez A, Desrivieres S, Jahanshad N, Toro R, Wittfeld K, Abramovic L, Andersson M, et al. 2015. Common genetic variants influence human subcortical brain structures. Nature. 520(7546):224–229.
   PubMed Web of Science ®Google Scholar
• Inestrosa N C, Varela-Nallar L. 2014. Wnt signaling in the nervous system and in Alzheimer's disease. J Mol Cell Biol. 6(1):64–74.
   PubMed Web of Science ®Google Scholar
• Jaafari N, Konopacki FA, Owen TF, Kantamneni S, Rubin P, Craig TJ, Wilkinson KA, Henley JM. 2013. SUMOylation is required for glycine-induced increases in AMPA receptor surface expression (ChemLTP) in hippocampal neurons. PLoS One. 8(1):e52345.
   PubMed Web of Science ®Google Scholar
• Jakobsson E, Arguello-Miranda O, Chiu SW, Fazal Z, Kruczek J, Nunez-Corrales S, Pandit S, Pritchet L. 2017. Towards a unified understanding of lithium action in basic biology and its significance for applied Biology. J Membr Biol. 250(6):587–604.
   PubMed Web of Science ®Google Scholar
• Joshi CR, Stacy S, Sumien N, Ghorpade A, Borgmann K. 2020. Astrocyte HIV-1 Tat differentially modulates behavior and brain MMP/TIMP balance during short and prolonged induction in transgenic mice. Front Neurol. 11:593188.
   PubMed Web of Science ®Google Scholar
• Kaul M, Garden GA, Lipton SA. 2001. Pathways to neuronal injury and apoptosis in HIV-associated dementia. Nature. 410(6831):988–994.
   PubMed Web of Science ®Google Scholar
• Kim BO, Liu Y, Ruan Y, Xu ZC, Schantz L, He JJ. 2003. Neuropathologies in transgenic mice expressing human immunodeficiency virus type 1 Tat protein under the regulation of the astrocyte-specific glial fibrillary acidic protein promoter and doxycycline. Am J Pathol. 162(5):1693–1707.
   PubMed Web of Science ®Google Scholar
• Kim HJ, Martemyanov KA, Thayer SA. 2008. Human immunodeficiency virus protein Tat induces synapse loss via a reversible process that is distinct from cell death. J Neurosci. 28(48):12604–12613.
   PubMed Web of Science ®Google Scholar
• Kim HJ, Thayer SA. 2009. Lithium increases synapse formation between hippocampal neurons by depleting phosphoinositides. Mol Pharmacol. 75(5):1021–1030.
   PubMed Web of Science ®Google Scholar
• Kim JH, Chung KH, Hwang YR, Park HR, Kim HJ, Kim HG, Kim HR. 2021. Exposure to RF-EMF alters postsynaptic structure and hinders neurite outgrowth in developing hippocampal neurons of early postnatal mice. Int J Mol Sci. 22:10.
   Web of Science ®Google Scholar
• King JE, Eugenin EA, Buckner CM, Berman JW. 2006. HIV tat and neurotoxicity. Microbes Infect. 8(5):1347–1357.
   PubMed Web of Science ®Google Scholar
• Krogh KA, Lyddon E, Thayer SA. 2015. HIV-1 Tat activates a RhoA signaling pathway to reduce NMDA-evoked calcium responses in hippocampal neurons via an actin-dependent mechanism. J Neurochem. 132(3):354–366.
   PubMed Web of Science ®Google Scholar
• Letendre SL, Woods SP, Ellis RJ, Atkinson JH, Masliah E, van den Brande G, Durelle J, Grant I, Everall I, Group H. 2006. Lithium improves HIV-associated neurocognitive impairment. AIDS. 20(14):1885–1888.
   PubMed Web of Science ®Google Scholar
• Licht R W. 2012. Lithium: still a major option in the management of bipolar disorder. CNS Neurosci Ther. 18(3):219–226.
   PubMed Web of Science ®Google Scholar
• Lowthert L, Leffert J, Lin A, Umlauf S, Maloney K, Muralidharan A, Lorberg B, Mane S, Zhao H, Sinha R, et al. 2012. Increased ratio of anti-apoptotic to pro-apoptotic Bcl2 gene-family members in lithium-responders one month after treatment initiation. Biol Mood Anxiety Disord. 2:15.
   PubMedGoogle Scholar
• Ma J, Zhang GY. 2003. Lithium reduced N-methyl-D-aspartate receptor subunit 2A tyrosine phosphorylation and its interactions with Src and Fyn mediated by PSD-95 in rat hippocampus following cerebral ischemia. Neurosci Lett. 348(3):185–189.
   PubMed Web of Science ®Google Scholar
• Machado-Vieira R, Manji HK, Zarate CA, Jr. 2009. The role of lithium in the treatment of bipolar disorder: convergent evidence for neurotrophic effects as a unifying hypothesis. Bipolar Disord. 11(Suppl 2):92–109.
   PubMed Web of Science ®Google Scholar
• Maggirwar SB, Tong N, Ramirez S, Gelbard HA, Dewhurst S. 1999. HIV-1 Tat-mediated activation of glycogen synthase kinase-3beta contributes to Tat-mediated neurotoxicity. J Neurochem. 73(2):578–586.
   PubMed Web of Science ®Google Scholar
• Manji HK, Moore GJ, Chen G. 1999. Lithium at 50: have the neuroprotective effects of this unique cation been overlooked? Biol Psychiatry. 46(7):929–940.
   PubMed Web of Science ®Google Scholar
• Nassar A, Azab AN. 2014. Effects of lithium on inflammation. ACS Chem Neurosci. 5(6):451–458.
   PubMed Web of Science ®Google Scholar
• Qaswal AB. 2020. Lithium stabilizes the mood of bipolar patients by depolarizing the neuronal membrane Via quantum tunneling through the sodium channels. Clin Psychopharmacol Neurosci. 18(2):214–218.
   PubMed Web of Science ®Google Scholar
• Raybuck JD, Hargus NJ, Thayer SA. 2017. A GluN2B-selective NMDAR antagonist reverses synapse loss and cognitive impairment produced by the HIV-1 protein Tat. J Neurosci. 37(33):7837–7847.
   PubMed Web of Science ®Google Scholar
• Rubin LH, Maki PM. 2019. HIV, depression, and cognitive impairment in the era of effective antiretroviral therapy. Curr HIV/AIDS Rep. 16(1):82–95.
   PubMed Web of Science ®Google Scholar
• Sa MJ, Madeira MD, Ruela C, Volk B, Mota-Miranda A, Paula-Barbosa MM. 2004. Dendritic changes in the hippocampal formation of AIDS patients: a quantitative Golgi study. Acta Neuropathol. 107(2):97–110.
   PubMed Web of Science ®Google Scholar
• Sarno De, Axtell P, Raman R C, Roth C, Alessi K A, Jope D R. 2008. Lithium prevents and ameliorates experimental autoimmune encephalomyelitis. J Immunol. 181(1):338–345.
   PubMed Web of Science ®Google Scholar
• Schifitto G, Peterson DR, Zhong J, Ni H, Cruttenden K, Gaugh M, Gendelman HE, Boska M, Gelbard H. 2006. Valproic acid adjunctive therapy for HIV-associated cognitive impairment: a first report. Neurology. 66(6):919–921.
   PubMed Web of Science ®Google Scholar
• Song L, Nath A, Geiger JD, Moore A, Hochman S. 2003. Human immunodeficiency virus type 1 Tat protein directly activates neuronal N-methyl-D-aspartate receptors at an allosteric zinc-sensitive site. J Neurovirol. 9(3):399–403.
   PubMed Web of Science ®Google Scholar
• Tozzi V, Balestra P, Lorenzini P, Bellagamba R, Galgani S, Corpolongo A, Vlassi C, Larussa D, Zaccarelli M, Noto P, et al. 2005. Prevalence and risk factors for human immunodeficiency virus-associated neurocognitive impairment, 1996 to 2002: results from an urban observational cohort. J Neurovirol. 11(3):265–273.
   PubMed Web of Science ®Google Scholar
• Waataja JJ, Kim HJ, Roloff AM, Thayer SA. 2008. Excitotoxic loss of post-synaptic sites is distinct temporally and mechanistically from neuronal death. J Neurochem. 104(2):364–375.
   PubMed Web of Science ®Google Scholar
• Wada A, Yokoo H, Yanagita T, Kobayashi H. 2005. Lithium: potential therapeutics against acute brain injuries and chronic neurodegenerative diseases. J Pharmacol Sci. 99(4):307–321.
   PubMed Web of Science ®Google Scholar
• Watase K, Gatchel J R, Sun Y, Emamian E, Atkinson R, Richman R, Mizusawa H, Orr H T, Shaw C, Zoghbi H Y. 2007. Lithium therapy improves neurological function and hippocampal dendritic arborization in a spinocerebellar ataxia type 1 mouse model. PLoS Med. 4(5).
   PubMed Web of Science ®Google Scholar
• Wexler EM, Geschwind DH, Palmer TD. 2008. Lithium regulates adult hippocampal progenitor development through canonical Wnt pathway activation. Mol Psychiatry. 13(3):285–292.
   PubMed Web of Science ®Google Scholar
• Woo DH, Hur Y-N, Jang MW, Lee CJ, Park M. 2020. Inhibitors of synaptic vesicle exocytosis reduce surface expression of postsynaptic glutamate receptors. Anim Cells Syst. 24(6):341–348.
   PubMed Web of Science ®Google Scholar
• Woods SP, Moore DJ, Weber E, Grant I. 2009. Cognitive neuropsychology of HIV-associated neurocognitive disorders. Neuropsychol Rev. 19(2):152–168.
   PubMed Web of Science ®Google Scholar
• Youdim M B, Arraf Z. 2004. Prevention of MPTP (N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) dopaminergic neurotoxicity in mice by chronic lithium: involvements of Bcl-2 and Bax. Neuropharmacology. 46(8):1130–1140.
   Web of Science ®Google Scholar
• Young W. 2009. Review of lithium effects on brain and blood. Cell Transplant. 18(9):951–975.
   PubMed Web of Science ®Google Scholar